Publicaciones en las que colabora con JOSÉ ÁNGEL GARCÍA SÁENZ (6)

2014

  1. 18F-FDG PET-CT imaging in the neoadjuvant setting for stages II-III breast cancer: Association of loco-regional SUVmax with classical prognostic factors

    Quarterly Journal of Nuclear Medicine and Molecular Imaging, Vol. 58, Núm. 1, pp. 66-73

  2. Assignment of tumor subtype by genomic testing and pathologic-based approximations: Implications on patient's management and therapy selection

    Clinical and Translational Oncology, Vol. 16, Núm. 4, pp. 386-394

2013

  1. Correlation between response to neoadjuvant chemotherapy and survival in locally advanced breast cancer patients

    Annals of Oncology, Vol. 24, Núm. 3, pp. 655-661

2012

  1. Glutathione S-transferase P1 c.313a > G polymorphism could be useful in the prediction of doxorubicin response in breast cancer patients

    Annals of Oncology, Vol. 23, Núm. 7, pp. 1750-1756

  2. Prospective transGEICAM study of the impact of the 21-gene recurrence score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancer

    Annals of Oncology, Vol. 23, Núm. 3, pp. 625-631

2011

  1. Genomic predictors of response to doxorubicin versus docetaxel in primary breast cancer

    Breast Cancer Research and Treatment, Vol. 128, Núm. 1, pp. 127-136